Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Akers Biosciences and Hainan Savy Investment create diagnostics JV in China

Executive Summary

Akers Biosciences Inc. and Hainan Savy Investment Management created the joint venture Hainan Savy Akers Biosciences Ltd., which will be tasked with developing, manufacturing, and selling Akers’ rapid diagnostics in China.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Joint Venture
    • R+D and Marketing-Licensing

Related Companies